Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GTHX | Common Stock | Award | $0 | +10K | +100% | $0.00 | 20K | Jun 13, 2024 | Direct | F1, F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GTHX | Stock Options (Right to Buy) | Award | $0 | +30K | $0.00 | 30K | Jun 13, 2024 | Common Stock | 30K | $2.99 | Direct | F4 |
Id | Content |
---|---|
F1 | Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 13, 2024, subject to the Reporting Person's continued service as a director. The Reporting Person has elected to defer vesting of these shares pursuant to the G1 Therapeutics, Inc. Deferred Compensation Plan for Non-Employee Directors. The RSUs will vest upon termination of the Reporting Person's service as a Director on the Company's Board. |
F2 | Each RSU represents a contingent right to receive one share of Issuer common stock. |
F3 | Represents (i) 10,000 RSUs from award granted on June 15, 2023; and (ii) 10,000 RSUs from award granted on June 13, 2024. |
F4 | The shares underlying this option will vest in their entirety twelve months after June 13, 2024, subject to the Reporting Person's continued service as a director. |